Your browser doesn't support javascript.
loading
Selexipag, an Oral Prostacyclin-Receptor Agonist for Pulmonary Arterial Hypertension.
Baker, William L; Darsaklis, Konstadina; Singhvi, Aditi; Salerno, Edward L.
Affiliation
  • Baker WL; 1 University of Connecticut, Storrs, CT, USA.
  • Darsaklis K; 2 Center for Advanced Heart Failure and Transplant, Hartford, CT, USA.
  • Singhvi A; 3 University of Connecticut/Hartford Hospital, CT, USA.
  • Salerno EL; 4 University of Connecticut School of Medicine, Hartford, CT, USA.
Ann Pharmacother ; 51(6): 488-495, 2017 Jun.
Article in En | MEDLINE | ID: mdl-28478717
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrazines / Hypertension, Pulmonary / Acetamides Type of study: Clinical_trials / Guideline / Health_economic_evaluation / Systematic_reviews Limits: Humans Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2017 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrazines / Hypertension, Pulmonary / Acetamides Type of study: Clinical_trials / Guideline / Health_economic_evaluation / Systematic_reviews Limits: Humans Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2017 Type: Article Affiliation country: United States